Alexander Egeberg

Background

About Alexander Egeberg

I am a strategic senior executive leader with a robust track record in global pharmaceutical companies and a strong scientific background. My experience spans R&D, global medical strategies, worldwide product launches, clinical trial design and execution, real-world evidence generation, regulatory interactions and submissions, business development, and strategic lifecycle planning. With proven leadership as Vice President (CEO -2), I have led organizations of over 250 professionals across Dermatology, Thrombosis, and Oncology Business Units. My work focuses on biologics, oral small molecules, and topical therapies, driving innovation and delivering impactful results. As a globally recognized leader, I bring a unique combination of executive experience and academic excellence. I am a board-certified dermatologist and Full Professor with a deep understanding of inflammatory diseases. I have authored over 400 scientific publications in prestigious journals, including The New England Journal of Medicine and The Lancet. My expertise extends across dermatology, rheumatology, and gastroenterology, with a focus on disease trajectories, clinical trials, real-world evidence, and biomarkers. I am committed to advancing science, improving patient outcomes, and fostering collaboration across disciplines to drive meaningful change in healthcare.